Latest Product Updates and Feature Enhancements on REVO
ZS Releases Research on Early Personalization in Pharmaceutical Launch Planning - USA Today
ZS has released research focusing on early personalization in pharmaceutical launch planning. The study highlights the importance of integrating personalized engagement strategies during the initial ...market entry phases, rather than post-launch. It identifies challenges such as limited customer data access and fragmented systems, and explores the potential of generative AI in enhancing launch planning frameworks.
ZS and Cerebras Systems Partner to Set a New Bar in Enterprise Agentic AI
ZS and Cerebras Systems have partnered to enhance ZS's MAX.AI platform with Cerebras' CS-3 hardware, significantly boosting AI training speeds. This collaboration aims to deliver faster, cost-effecti...ve AI solutions tailored to enterprise needs, leveraging Cerebras' advanced hardware and ZS's AI expertise.
SightX and ZS Announce Strategic Partnership to Transform Consumer Research
SightX and ZS have formed a strategic partnership to enhance consumer research capabilities. This collaboration aims to integrate advanced analytics and insights, helping organizations make data-driv...en decisions. The partnership will leverage both companies expertise to deliver innovative solutions for market research and consumer behavior analysis.
ZS expands partnership with Salesforce to help companies scale AI agents with Agentforce - Business Wire
Zoho Corp. has expanded its R&D efforts by launching a new campus in Kottarakkara, Kerala, acquiring Asimov Robotics, and partnering with the Kerala Startup Mission for a Deep Tech Product Studio ini...tiative. These moves aim to boost innovation in AI and robotics, leveraging local talent and enhancing deep-tech capabilities in India.
Awards, Recognitions, and Industry Achievements of REVO
ZS to introduce ZAIDYN intelligence into Agentforce Life Sciences - PR Newswire
ZS has been recognized as a Leader in the IDC MarketScape: Worldwide Life Sciences R&D AI in Clinical Trials 2025 Vendor Assessment. This accolade highlights ZS's strengths in providing AI-driven ins...ights and scalable solutions for clinical trials. ZS's AI models achieve high accuracy and offer significant improvements in generating novel insights, supporting life sciences companies in digital transformation and AI adoption.
ZS named Databricks 2025 Life Sciences Partner of the Year - Business Wire
ZS has been named the Databricks 2025 Life Sciences Partner of the Year at the Data + AI Summit. This award recognizes ZSs impact in advancing data management and analytics for life sciences organiza...tions, highlighting its expertise in deploying Databricks solutions to drive better insights and outcomes in the sector.
ZS expands GCC presence with new office in Hyderabad
ZS has opened a new 50,000 square foot office in Hyderabad to expand its global capability center offerings. This office will house around 600 employees and provide flexible engagement models, includ...ing GCC-as-a-service. ZS aims to support the transformation of GCCs into innovation and tech centers, particularly in healthcare and life sciences, leveraging Hyderabad's robust talent and tech ecosystem.